Evidence map›Paper›PMID 25516985›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

In vivo anticancer activity of rhomboidal Pt(II) metallacycles.

Ivan V Grishagin, J Bryant Pollock, Swati Kushal, Timothy R Cook, Peter J Stang, Bogdan Z Olenyuk

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Article
  3. Dual-Emissive Rectangular Supramolecular Pt(II)-Molecules (Basel, Switzerland) · 2023
    Article
  4. Metal-Coordinated Supramolecular Self-Assemblies for Cancer Theranostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Supramolecular Metallacycles and Their Binding of Fullerenes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020
    Article
  10. Article
  11. Biomedically Relevant Self-Assembled Metallacycles and Metallacages.Journal of the American Chemical Society · 2019
    Review
  12. Article
  13. Article
  14. Subcellular Duplex DNA and G-Quadruplex Interaction Profiling of a Hexagonal PtAngewandte Chemie (International ed. in English) · 2019
    Article
  15. Article
  16. Rhomboidal Pt(II) metallacycle-based NIR-II theranostic nanoprobe for tumor diagnosis and image-guided therapy.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ivan V GrishaginSchool of Pharmacy, University of Southern California, Los Angeles, CA 90089; and.
J Bryant PollockDepartment of Chemistry, University of Utah, Salt Lake City, UT 84112.
Swati KushalSchool of Pharmacy, University of Southern California, Los Angeles, CA 90089; and.
Timothy R CookDepartment of Chemistry, University of Utah, Salt Lake City, UT 84112.
Peter J StangDepartment of Chemistry, University of Utah, Salt Lake City, UT 84112 stang@chem.utah.edu bogdan@usc.edu.
Bogdan Z OlenyukSchool of Pharmacy, University of Southern California, Los Angeles, CA 90089; and stang@chem.utah.edu bogdan@usc.edu.
University of Southern California · USUniversity of Utah · US

Funding

POLYVALENT IODINE AND DERIVED CHEMISTRYR01GM057052 · NIGMS · UNIVERSITY OF UTAH · PI STANG, PETER J · 1998 to 2012
$3.3M
NIGMS NIH HHS GM-057052NIGMS NIH HHS R01 GM057052
6 · The paper itself

Abstract

The development of novel antitumor agents that have high efficacy in suppressing tumor growth, have low toxicity to nontumor tissues, and exhibit rapid localization in the targeted tumor sites is an ongoing avenue of research at the interface of chemistry, cancer biology, and pharmacology. Supramolecular metal-based coordination complexes (SCCs) have well-defined shapes and geometries, and upon their internalization, SCCs could affect multiple oncogenic signaling pathways in cells and tissues. We investigated the uptake, intracellular localization, and antitumor activity of two rhomboidal Pt(II)-based SCCs. Laser-scanning confocal microscopy in A549 and HeLa cells was used to determine the uptake and localization of the assemblies within cells and their effect on tumor growth was investigated in mouse s.c. tumor xenograft models. The SCCs are soluble in cell culture media within the entire range of studied concentrations (1 nM-5 µM), are nontoxic, and showed efficacy in reducing the rate of tumor growth in s.c. mouse tumor xenografts. These properties reveal the potential of Pt(II)-based SCCs for future biomedical applications as therapeutic agents.

Indexed as

Antineoplastic AgentsOrganometallic CompoundsPlatinumAnimalsHeLa CellsHumansMiceNeoplasms, ExperimentalSignal TransductionXenograft Model Antitumor AssaysAntineoplastic AgentsOrganometallic CompoundsPlatinumcell culturefluorescencesupramolecular coordination complexestumor growthxenografts

Identifiers

PMID25516985
PMCPMC4284546
OpenAlexW2107325832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.